Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Language
Publication year range
1.
Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.
Merkac, Maja Ivartnik; Tomazic, Janez; Strle, Franc.
Infection ; 43(6): 759-62, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25922085

ABSTRACT

A 57-year-old woman, receiving TNF-alpha inhibitor adalimumab for psoriasis, presented with early Lyme neuroborreliosis (Bannwarth's syndrome). Discontinuation of adalimumab and 14-day therapy with ceftriaxone resulted in a smooth course and favorable outcome of Lyme borreliosis. This is the first report on Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.


Subject(s)
Adalimumab/administration & dosage , Immunologic Factors/administration & dosage , Lyme Neuroborreliosis/diagnosis , Lyme Neuroborreliosis/pathology , Psoriasis/complications , Psoriasis/drug therapy , Anti-Bacterial Agents/administration & dosage , Ceftriaxone/administration & dosage , Female , Humans , Lyme Neuroborreliosis/drug therapy , Middle Aged , Treatment Outcome
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL